(Q39446450)

12 September 2017

title

Nitrate therapy may retard glaucomatous optic neuropathy, perhaps through modulation of glutamate receptors (English)

1 reference

12 September 2017

Zurakowski D

1

1 reference

12 September 2017

Vorwerk CK

2

1 reference

12 September 2017

Gorla M

3

1 reference

12 September 2017

Kanellopoulos AJ

4

1 reference

12 September 2017

Chaturvedi N

5

1 reference

12 September 2017

Grosskreutz CL

6

1 reference

12 September 2017

Lipton SA

7

1 reference

12 September 2017

Dreyer EB

8

1 reference

12 September 2017

publication date

1 May 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

38

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

1489-1494

1 reference

Amyl nitrite test in primary glaucoma

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

USE OF NITRATE AND NITRITE VASODILATORS BY GLAUCOMATOUS PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

The toxic effect of sodium L-glutamate on the inner layers of the retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Selective modulation of NMDA responses by reduction and oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Nitric oxide-induced blockade of NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Effect of chronic nitrate treatment on retinal vessel caliber in open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

Glutathione prevents N -methyl-d-aspartate receptor-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6989%2898%2900003-0

7 January 2021

10.1016/S0042-6989(98)00003-0

Identifiers

DOI

1 reference

12 September 2017

1 reference